Associations of exposure to perchlorate, thiocyanate, and nitrate with metabolic dysfunction-associated steatotic liver disease: Evidence from a population-based cross-sectional study in the United States

被引:0
|
作者
Chen, Jiajin [1 ]
Lu, Liyong [2 ,3 ]
Nie, Xiaoqing [1 ]
Li, Jiawei [4 ]
Chen, Tingxuan [5 ]
Li, Sicheng [1 ]
机构
[1] Xiamen Univ, Xiamen Cardiovasc Hosp, Sch Med, 2999 Jinshan Rd, Xiamen 361006, Fujian, Peoples R China
[2] Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Shandong, Peoples R China
[3] Shandong Univ, NHC Key Lab Hlth Econ & Policy Res, Jinan, Shandong, Peoples R China
[4] Sichuan Univ, West China Hosp 4, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu, Sichuan, Peoples R China
[5] Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China
关键词
OXIDATIVE STRESS; OBESITY; IODIDE;
D O I
10.1016/j.jclepro.2024.143156
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Perchlorate, thiocyanate, and nitrate (PTN) are prevalent environmental endocrine disruptors in humanaccessible environments. However, the available evidence regarding the relationship between PTN and liver impairment, especially metabolic dysfunction-associated fatty liver disease (MASLD), remains limited. Therefore, the present study aimed to investigate the associations between PTN and MASLD. Participant data from the National Health and Nutrition Examination Surveys 2017-2020, a cross-sectional survey of the US population, were included in the present study. Ion chromatography-electrospray tandem mass spectrometry was employed to measure PTN levels. Vibration-controlled transient elastography and metabolic indicators were used to diagnose MASLD. Logistic regression models and multiple exposure methods (including weighted quantile sum, quantile G-computation, and Bayesian kernel machine regression) were used to evaluate the associations of individual and combined PTN exposure with MASLD. Causal mediation analyses were used to explore potential mediators. Among the 1393 participants (mean [SD] age, 50.41 [16.78] years; 52.26% female) included, 472 (33.9%) had MASLD. A unit increase in natural log-transformed perchlorate (OR = 1.180, 95% CI: 1.041-1.374) and nitrate (0.797, 0.657-0.967) was significantly associated with MASLD, while thiocyanate (1.024, 0.906-1.157) did not exhibit a significant association with MASLD. Moreover, combined PTN exposure was not significantly associated with MASLD, and perchlorate and nitrate were identified as the most crucial exposures for increasing and decreasing MASLD risk, respectively. Furthermore, biological age (proportion mediated = 15.2%, P = 0.035) and its acceleration (15.0%, 0.037) may mediate the perchlorate-MASLD association. In conclusion, these findings suggested that exposure to perchlorate increases the risk of MASLD, whereas nitrate mitigates this risk. Additionally, combined PTN exposure is not significantly associated with MASLD, and biological age mediates the perchlorate-MASLD association.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Associations of perchlorate, nitrate, and thiocyanate with metabolic syndrome and its components among US adults: A cross-sectional study from NHANES
    Guo, Xianwei
    Wu, Birong
    Hu, Wenjing
    Wang, Xingyue
    Su, Wenqi
    Meng, Jia
    Lowe, Scott
    Zhao, Dongdong
    Huang, Christy
    Liang, Mingming
    Qu, Guangbo
    Zhou, Xiaoqin
    Sun, Yehuan
    SCIENCE OF THE TOTAL ENVIRONMENT, 2023, 879
  • [22] Association of food intake with a risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study
    Huang, Xian-Hua
    Peng, He-Wei
    Huang, Jing-Ru
    Yu, Rong
    Hu, Zhi-Jian
    Peng, Xian-E
    GASTROENTEROLOGY REPORT, 2023, 11
  • [23] Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
    Fan Zhang
    Longgen Liu
    Wenjian Li
    Nutrition Journal, 24 (1)
  • [24] Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study
    Yanli Zhang
    Zhang Xia
    Xueli Cai
    Xin Su
    Aoming Jin
    Lerong Mei
    Jing Jing
    Suying Wang
    Xia Meng
    Shan Li
    Mengxing Wang
    Tiemin Wei
    Yongjun Wang
    Yan He
    Yuesong Pan
    Cardiovascular Diabetology, 22
  • [25] Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study
    Zhang, Yanli
    Xia, Zhang
    Cai, Xueli
    Su, Xin
    Jin, Aoming
    Mei, Lerong
    Jing, Jing
    Wang, Suying
    Meng, Xia
    Li, Shan
    Wang, Mengxing
    Wei, Tiemin
    Wang, Yongjun
    He, Yan
    Pan, Yuesong
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [26] Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center
    Yokoyama, Shinya
    Honda, Takashi
    Ishizu, Yoji
    Imai, Norihiro
    Ito, Takanori
    Yamamoto, Kenta
    Mizuno, Kazuyuki
    Kojima, Tetsuhito
    Kariya, Naoyoshi
    Nakamura, Masanao
    Kawashima, Hiroki
    CLINICAL NUTRITION, 2024, 43 (06) : 1425 - 1432
  • [27] Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study
    Sung, Ki-Chul
    Yoo, Tae Kyung
    Lee, Mi Yeon
    Byrne, Christopher D.
    Zheng, Ming-Hua
    Targher, Giovanni
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (03) : 482 - 491
  • [28] Association between the composite dietary antioxidant index and metabolic dysfunction-associated steatotic liver disease in adults: a cross-sectional study from NHANES 2017-2020
    Yang, Zheng
    Song, Shupeng
    Li, Lufeng
    Yuan, Zhe
    Li, Yongguo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [29] High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia
    Valery, Patricia C.
    Roche, Shruti
    Brown, Catherine
    O'Beirne, James
    Hartel, Gunter
    Leggett, Barbara
    Skoien, Richard
    Powell, Elizabeth E.
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2024, 23 (01)
  • [30] Association between metabolic dysfunction-associated steatotic liver disease and pulmonary function: a population-based and two-sample mendelian randomization study
    Feng, Ting
    Li, Jiaming
    Wu, Lihao
    He, Xingxiang
    Ye, Junzhao
    BMC PULMONARY MEDICINE, 2024, 24 (01):